IRMD - IRadimed Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5217.61M
Enterprise Value 3182.88M
Trailing P/E 29.09
Forward P/E 119.14
PEG Ratio (5 yr expected) 11.59
Price/Sales (ttm)6.47
Price/Book (mrq)4.55
Enterprise Value/Revenue 35.44
Enterprise Value/EBITDA 622.64

Trading Information

Stock Price History

Beta (3Y Monthly) 1.99
52-Week Change 3-31.81%
S&P500 52-Week Change 31.68%
52 Week High 338.78
52 Week Low 316.68
50-Day Moving Average 320.22
200-Day Moving Average 323.45

Share Statistics

Avg Vol (3 month) 378.3k
Avg Vol (10 day) 348.15k
Shares Outstanding 511.37M
Float 5.38M
% Held by Insiders 154.87%
% Held by Institutions 123.43%
Shares Short (Jul 31, 2019) 4457.73k
Short Ratio (Jul 31, 2019) 43.88
Short % of Float (Jul 31, 2019) 48.89%
Short % of Shares Outstanding (Jul 31, 2019) 44.03%
Shares Short (prior month Jun 28, 2019) 4514.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 23.92%
Operating Margin (ttm)21.21%

Management Effectiveness

Return on Assets (ttm)8.94%
Return on Equity (ttm)19.30%

Income Statement

Revenue (ttm)33.62M
Revenue Per Share (ttm)3.06
Quarterly Revenue Growth (yoy)25.10%
Gross Profit (ttm)23.23M
EBITDA 8.08M
Net Income Avi to Common (ttm)8.04M
Diluted EPS (ttm)0.66
Quarterly Earnings Growth (yoy)54.20%

Balance Sheet

Total Cash (mrq)37.8M
Total Cash Per Share (mrq)3.33
Total Debt (mrq)3.07M
Total Debt/Equity (mrq)6.51
Current Ratio (mrq)10.29
Book Value Per Share (mrq)4.21

Cash Flow Statement

Operating Cash Flow (ttm)7.42M
Levered Free Cash Flow (ttm)3.94M